Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets.
The acquisition includes the Extract Technology businesses which are, headquartered in Huddersfield (UK), and Extract Americas (Formerly, Walker Barrier Systems), located in New Lisbon, Wisconsin (USA).
Extract Technology has a successful track record of developing innovative containment solutions for leading global clients. Coupled with the critical nature of the systems, Extract has developed significant longstanding customer relationships. The product offering is complemented by strong aftermarket services.
The acquisition supports Dec’s strategic approach to complementary technology acquisition, and specifically focuses on growing our Containment Solutions Technologies (Dec CST) product portfolio, in addition to expanding our manufacturing capabilities in the UK/EU market, and the growing North American market.
Extract further enhances the Dec Group’s Isolation capabilities for critical & highly potent applications. The combined complementary portfolios will lead to a higher degree of customer integration solutions, offering a clear customer value proposition as an expert on all levels.
Dec’s Managing Directors Yves and Frederic Dietrich comment, “Enhancing our capabilities within the containment technology portfolio sits at the heart of the Dec Group, the ability to contain customer product to support safety, product integrity & improve efficiency are founding principles of the company. Today we have been able to expand our containment product portfolio to include new portfolio technologies, expand end-markets into areas such as Nuclear, and expand our global reach through two new manufacturing facilities in the UK & the USA, which will ultimately benefit the existing Dec business”.
On behalf of The Dec Group, Andrew Milner (CEO, Dec-USA) will lead the integration process alongside Alan Wainwright (Managing Director, Extract Technology).